Fig. 3

Expression patterns of AURKA in GISTs and other human malignancies. A Immunohistochemical (IHC) staining of GIST specimens. I: strong staining, II: intermediate staining, III: weak staining. B IHC scores of AURKA varied across different GIST risk groups, with high-risk GISTs showing the highest expression of AURKA. C Patients with elevated AURKA expression levels exhibited poorer DFS than those with low AURKA expression levels. D The Oncomine and GEPIA databases showed a significant upregulation of AURKA expression in most human malignancies compared to normal tissues